JTTT

10.3000.00%
SS

Someit Sidhu

Founder, Chairman & CEO

Dr. Someit Sidhu, MD, is Chairman & CEO of JATT III Acquisition Corp. He is the Founder, Chairman and Chief Executive Officer of JATT II Acquisition Corp. since January 13, 2026. Dr. Sidhu was CEO & Chairman of Jatt Acquisition Corp. Dr. Sidhu is the Co-Founder and had been the CEO of Akaza Bioscience since 2019 until 2021 and the CEO of Izana Bioscience since November 2017 until June 2020. He is the Co-Founder of Pathios Therapeutics. Dr. Sidhu Co-Founded Zura Bio Limited and served as its Chief Executive Officer since March 21, 2023 until April 08, 2024. Dr. Sidhu served as Non-Independent Director of Zura Bio Limited since March 21, 2023 until May 21, 2026. Dr. Sidhu has broad expertise covering various topics in the life sciences industry. Prior to these companies, he advised many large international pharmaceutical companies as a management consultant at McKinsey & Co, where he primarily focused on Pharmaceutical R&D and Portfolio Strategy. Dr. Sidhu has also been serving as director of GSN Estate since September 2024 and as director of Invictus Bioscience since May 2016. Dr. Sidhu gained medical experience during his time in Cardiology and General Surgery after graduating from the Oxford Medical School where he was a Senior Mackinnon Scholar at Magdalen College.

Positions